ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,310Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 298

$507K Total Retail Price of All Prescriptions

Rank: 29 out of 298

482 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 482 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 482 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,680 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 661 463 1 1
SIMVASTATIN 366 287 2 2
FUROSEMIDE 359 290 3 5
OMEPRAZOLE 334 231 4 3
LOSARTAN POTASSIUM 208 190 5 18
WARFARIN SODIUM 189 179 6 7
POTASSIUM CHLORIDE 172 161 7 11
AMLODIPINE BESYLATE 170 153 8 6
METFORMIN HCL 158 82 9 10
ATENOLOL 157 151 10 16
TRAMADOL HCL 155 115 11 15
HYDROCODONE-ACETAMINOPHEN 155 82 S3 11 8
METOPROLOL SUCCINATE 154 147 13 12
GABAPENTIN 154 137 13 20
METOPROLOL TARTRATE 148 129 15 9
CARVEDILOL 135 103 16 23
LISINOPRIL 133 100 17 4
SPIRONOLACTONE 129 117 18 34
FLUOXETINE HCL 118 63 19 50
PREDNISONE 117 85 20 33
TAMSULOSIN HCL 113 96 21 24
DILTIAZEM 24HR CD 108 108 22 74
ATORVASTATIN CALCIUM 104 77 23 14
ZOLPIDEM TARTRATE 102 82 24 25
FINASTERIDE 96 79 25 66
ALLOPURINOL 95 83 26 28
SERTRALINE HCL 92 79 27 19
GEMFIBROZIL 90 63 28 65
DIVALPROEX SODIUM 78 36 29 91
DIGOXIN 77 65 30 27
DONEPEZIL HCL 73 53 31 22
FENOFIBRATE 73 61 31 62
GLYBURIDE-METFORMIN HCL 72 71 R 33 166
CITALOPRAM HBR 71 40 34 17
LOSARTAN-HYDROCHLOROTHIAZIDE 70 56 35 44
MIRTAZAPINE 70 64 35 37
TRIAMTERENE-HCTZ 67 33 37 43
PRAVASTATIN SODIUM 66 66 38 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 60 39 30
GLIMEPIRIDE 59 55 40 60
CRESTOR 59 41 40 26
HYDROCHLOROTHIAZIDE 56 56 42 13
MELOXICAM 55 39 43 41
FLUTICASONE PROPIONATE 54 26 44 38
NEXIUM 51 0 45 40
TORSEMIDE 51 51 45 110
CARBAMAZEPINE 50 18 47 105
AMITRIPTYLINE HCL 50 28 R 47 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.